Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesMolecular ImagingNeuroinflammation persists for 2 years in long COVIDIncreased inflammatory activity was found on TSPO-PET in some individuals with post-COVID syndrome.CT6 key ways to evaluate the heart on chest CT imaging in the EDUltrasoundUltrasound-guided biopsies effective in diagnosing lung cancerMolecular ImagingThe rise of theranostics: Part 6 -- Private practices pivot to clinical trialsSponsor Content"Join Us"